INSIGHTS ON LIQUID DOSE MANUFACTURING

• Afton Scientific Capabilities Update January 2026: Fill/Finish

  Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.

• Alba® Syringe Platform: Ensuring Stability For Sensitive Drugs

  Check out this exciting video showcasing the key advantages of Alba®: innovative coating technology that reduces potential interaction between the drug and container surface.

• MilliporeSigma Bio-Expo Live February 2025: Upstream Bioprocessing

  Review the benefits of implementing a closed and sterile sampling system, such as NovaSeptum®, to improve sampling procedures and meet regulatory expectations.

• Lyophilization To Enable Drug Products Containing Labile Molecules

  Develop lyophilized formulations to overcome stability challenges and significantly extend the shelf life of sensitive therapeutic products.

• Empowering Innovation: Harnessing CDMO Potential For Sterile Injectables

  10/20/2025

  Specialized CDMOs are essential for meeting the growing demand and complex quality requirements for sterile injectables. Outsourcing provides crucial benefits like cost savings, flexibility, and a strategic focus on core competencies.

• How Asia and Europe Are Reshaping Biologics Manufacturing

  4/9/2026

  As biologics manufacturing globalizes, companies must balance cost, capacity, risk, and control when choosing between European and Asian supply bases for clinical and commercial success.

• Cytiva's Aseptic Filling Workcell User Group

  1/9/2026

  Discover how global collaboration among aseptic filling experts is driving innovation and improving operations.

• Commercially Proven Sterile Fill/Finish With Capacity And Global Backing

  1/27/2026

  Find comprehensive solution with new sterile fill/finish investments supporting complex molecules through robust tech transfer, commercialization expertise, and integrated cGMP manufacturing solutions.

• Product-Wet Integrity Testing: Risk-Based Strategies

  5/22/2026

  When standard water‑based integrity testing falls short, product‑wet approaches can offer a more representative alternative. Learn how risk‑based strategies are used to establish reliable test limits.